Depression and Anxiety Trial, Recruiting NCT06805851 Sponsor: Penn State University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06805851
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 40 years old who do not have depression
  • Adults between 18 and 40 years old who have been clinically diagnosed with major depressive disorder (MDD) and are not currently taking any antidepressant medication
  • Adults between 18 and 40 years old who have been clinically diagnosed with MDD and have been taking an SSRI-type antidepressant for at least 2 weeks
  • Adults between 18 and 40 years old who have been clinically diagnosed with MDD and have been taking an SNRI-type antidepressant for at least 2 weeks
  • People who have no current symptoms or warning signs such as chest pain, dizziness, joint pain, or signs of heart disease, based on standard exercise safety guidelines
  • People whose blood pressure readings at screening are at or below 140 (systolic) over 90 (diastolic)
  • People who do not have diabetes
  • People who are not taking other medications that could affect the body's physical responses being studied, such as beta blockers, certain older antidepressants, fever-reducing medicines, or water pills
  • People whose aerobic fitness level falls between the 20th and 80th percentile for their age and sex, based on standard fitness assessment guidelines (confirm with trial site)
  • People who are proficient in English
  • People who are able to understand and sign a consent form

Who may not be able to join:

  • People with a BMI over 35
  • People who are pregnant or planning to become pregnant within the next 12 months
  • People who are currently taking part in another study involving physical activity or weight loss
  • People who plan to have surgery or move out of the area within the next year
  • People taking medications that could affect how the heart or body temperature responds to exercise, such as beta blockers, fever-reducing medicines, certain older antidepressants, or water pills
  • People with an allergy to latex or adhesive materials
  • People who use tobacco products
  • People who use illegal or recreational drugs
  • People who experience chest pain or muscle or joint pain during physical activity
  • People who have a medical reason that would prevent them from safely completing a maximum-effort exercise test, based on standard exercise safety guidelines (confirm with trial site)
  • People who have an abnormal heart rhythm reading at rest or during exercise
  • People with bleeding disorders, stomach ulcers, allergies to anti-inflammatory pain medicines (such as ibuprofen), asthma, kidney or liver problems, or who are taking blood-thinning medications
  • People with a history of Crohn's disease, diverticulitis, or similar bowel conditions
  • People who have been diagnosed with another psychiatric condition such as psychosis, schizophrenia, bipolar disorder, panic disorder, or obsessive compulsive disorder
  • People who are currently experiencing moderate to high levels of suicidal thoughts
  • People who have used mind-altering or psychiatric medications — other than SSRIs or SNRIs — within the past year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: W. Larry Kenney, The Pennsylvania State University

Phone: 814-863-1672

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Penn State University
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
1 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Skin blood flow; Local Sweat Rate; Core Temperature

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov